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Objectives: Assessment of the cell proliferation rate in tissues can be one of the markers for impending malignancy 
in precancers.  The state of activation and the proliferation activity of the cells can be assessed by the frequency of 
silver stained Nucleolar Organiser regions (AgNOR) within the nuclei which is significantly higher in malignant 
cells. The present study was carried out to analyze the distribution of the AgNOR in oral leukoplakia (OL) and oral 
squamous cell carcinoma (OSCC), and in their various histological grades, and to assess if the AgNOR distribution 
could give information on the malignant potentiality in premalignant lesions and aggressiveness of the malignant 
lesions.
Study design: The study specimens comprised of 35 archival cases, of which 15 cases were of OL and 20 cases of 
OSCC. The specimens were stained by hematoxylin and eosin and modified silver staining method of Ploton et al. 
for the Nucleolar Organiser Regions. The specimens were analyzed independently by the two observers and was 
further statistically analysed.
Results: The mean AgNOR count in OL was 2.80 ±0.50 and in cases of OSCC was 5.71± 1.08. The mean AgNOR 
count in OL cases of mild dysplasia was 2.59 ±0.66, in moderate dysplasia was 2.92± 0.43 and in severe dysplasia 
was 2.79. The mean AgNOR count in cases of well differentiated OSCC was 5.73± 1.62 and in cases of moderately 
differentiated OSCC was 5.67±1.19.
Conclusion: The mean AgNOR count was higher in cases of OSCC as compared to cases of OL, and the AgNOR 
counts increased with the increase in the grades of dysplasia indicating a higher proliferative rate with increase in 
dysplasia. 
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Introduction
Oral squamous cell carcinoma accounts for over 90% 
of oral cancer cases (1) and a small percentage of these 
cases are thought to develop from precancers like leu-
koplakia, lichen planus, oral submucous fibrosis etc. 
There is a striking difference in the incidence and the 
mortality rates across the world, with highest rates gene-
rally registered in a few developing countries including 
India, Pakistan and Bangladesh, where this is the most 
common form of cancer. In some parts of the world, in-
cluding the Indian subcontinent, oral cancer is a major 
health problem accounting for about 10% of the estima-
ted new cancers that occur in all parts of the body each 
year (1). Therefore early diagnosis and management of 
precancerous lesions and conditions is important. Seve-
ral methods have been used for the identification of pro-
liferating cells in tissue sections with the aim to use them 
as a marker for impending malignancy, one among them 
is Silver binding Nucleolar Organiser region (AgNOR) 
technique. This is a simple one step staining technique 
which overcomes the disadvantages of other techniques 
such as requirement of sophisticated equipment, techni-
cal expertise, cost and time consumption (2,3).
Nucleolar Organiser Regions (NOR)   are loops of DNA 
that encode ribosomal RNA and are considered impor-
tant in the synthesis of protein (4). They are located on 
the short arms of acrocentric chromosomes - 13, 14, 15, 
21 and 22 (5). It has been suggested that the number of 
AgNORs in a nucleus may reflect the state of activa-
tion and the proliferation activity of the cells (6) and /
or degree of malignant transformation of certain tissues 
(7). The amount of AgNOR is related to the cell cycle, 
increasingly progressive from Go to S-phase and is pro-
portional to the proliferative activity of neoplastic cells 
(8). A rapidly dividing tumor population is more likely 
to have a greater proportion of cells in the early stages 
of G1 before individual NORs have associated and are 
therefore more likely to be observed in greater numbers. 
Conversely tumors with low rate of cell proliferation are 
more likely to display a single NOR (8).
The silver staining technique neither identifies rRNA nor 
rDNA but the acidic proteins associated with these sites 
of rRNA transcription, these proteins are designated as 
B23, C23, ‘AgNOR’ proteins and RNA polymerase I (9). 
NORs have recently attracted much attention because 
of the claims that their frequency within the nuclei is 
significantly higher in malignant cells than in normal, 
reactive or benign neoplastic cells (9).
The aim of this study was to assess the cell prolifera-
tion rate with the use of the AgNOR technique in OL 
and OSCC. The objectives of the study were to analyze 
NOR related parameter in OL   and its various histolo-
gical grading and in OSCC and its various histological 
grading; and to assess the correlation in the difference 
between nucleolar organizer related parameters in OL 
and OSCC.
Fig.1. Photomicrographs of silver stained sections of oral leukoplakia (100x) - mild dysplasia (1a), moderate dysplasia (1b) and 
severe dysplasia (1c)  
Fig.2. Photomicrographs of silver stained sections of oral squamous cell carcinoma (100x) - well differentiated (2 a) and mode-
rately differentiated (2 b)
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Materials and Methods
The archival study specimens were taken from the outpa-
tient subjects of    the college Hospital, and comprised of 
35 paraffin embedded tissue specimens, of which were 
15 specimens of OL and 20 specimens of OSCC. The 
approval of the ethical committee of the college was ob-
tained prior to the study.
The paraffin embedded tissue specimens were sectioned 
using a Soft tissue microtome (LEICA RM 2025) and 
subsequently deparafinised on a hot plate and through 
xylene, and hydrated through alcohol and subsequently 
stained with hematoxylin and eosin, and silver stain and 
mounted on DPX. The enumeration was done under 
“LYNX N-200M” Trinocular microscope.
The paraffin embedded archival tissue specimens of 15 
specimens of OL were grouped histologically as no dys-
plasia, mild dysplasia (Fig. 1a), moderate dysplasia (Fig. 
1b), severe dysplasia (Fig. 1c) (10), and that of 20 spe-
cimens of OSCC as   grade I (Well differentiated) (Fig. 
2a),  grade II (Moderately differentiated) (Fig. 2b), grade 
III (Poorly differentiated).
Preparation of the AgNOR solution was done according 
to the method proposed by Ploton et al. (11)  by mixing 1 
part of ‘Solution A’ with 2 parts of ‘Solution B’ ( Solution 
A-2g of Gelatin in 100ml of 1% Formic acid; Solution 
B- 50% solution of Silver nitrate in distilled water). The 
solution was poured immediately after mixing on the 
slides and placed in a dark chamber for 40 minutes. The 
silver nitrate solution deteriorates on standing, so the so-
lution had to be freshly prepared each time before use.
AgNOR counting was done as per the method proposed 
by Giri et al. (5), where in counting of all the specimens 
was done independently by two observers.200 cells were 
counted using a X100 objective, under oil immersion. 
The number of individually discernable and separable 
black dots in each nucleus was recorded and the average 
for each case computed; where two or more dots were 
so closely aggregated within a nucleolus that the precise 
number within the aggregate could not be counted, the 
aggregate was recorded as one. Inter-observer differen-
ces were recorded and cases with a difference in excess 
of one was reassessed. The average of that obtained by 
the two observers represented the final mean AgNOR 
count for a given case. This data was further statistically 
analyzed. 
In cases of OL NOR’s  presented as small round dots 
which were aggregated within the nucleolus as compa-
red with cases of OSCC where the NOR’s  presented 
with larger contours and were dispersed within the nu-
cleolus which could be easily counted.
Statistical Analysis
The data collected was analyzed independently by two 
observers and the average of both the values obtained 
by two observers was obtained for each case, and this 
was tabulated as the average AgNOR count. The mean 
AgNOR count and the standard deviation (SD) were 
calculated in cases of OL and OSCC.
SD was calculated using the formula:
SD=√∑d2/n-1
                                  Sum of the square of the difference
SD= Square root of   in mean and the individual sample 
                                   Number of the sample minus one
The interobserver variation between the two observers 
was calculated using the “Pearsons Co-relation coeffi-
cient” (r) using the formula:
r = covariance between the two variables /product of the 
standard deviation of the first and the second variable
The mean AgNOR values of OL and OSCC were com-
pared using the “ t test, for comparing the means of indi-
vidual samples”, using the formula:
t=ratio of difference between the two means to the stan-
dard error of difference between the means.
The mean AgNOR values of different grades of OL were 
calculated and were compared using the “Analysis of 
variance” (ANOVA) test, using the formula:
F=ratio of mean sum of squares between observations to 
mean sum of squares in observations
The mean AgNOR values of different grades of OSCC 
were calculated and were compared using the “ t test, for 
comparing the means of individual samples”, using the 
formula:
t=ratio of difference between the two means to the stan-
dard error of difference between the means.
Sensitivity =        True positives (TP)        X 100
                    (TP) + False negatives (FN)
Specificity =       True negatives (TN)         X 100
                     (TN) + False positives (FP)
Positive predictive value =         (TP)        X 100
                                             (TP) + (FP)
Negative predictive value =         (TP)         X 100
                                              (TN) + (FN)
Results
The inter observer variation between the two observers 
was calculated for both OL and OSCC after calculating 
the total AgNOR count in each group for each obser-
ver using the Pearsons correlation coefficient  and was 
















cell carcinoma 114.51 109.75 p<0.0001
Irrespective of the diagnosis (p<0.0001)
Table 1. Interobserver variation 
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Correlation of the mean AgNOR counts in 15 Archival 
specimens of OL was 2.80±0.50 (10 males and 5 fe-
males; age range of 35 to 63years) and in 20 archival 
specimens of OSCC was 5.71±1.08  (5 males and 15 
females; age range of 41 to 67years).  Comparison of 
AgNOR count in OL and OSCC was done using the “t 
test” and was found to be highly statistically  significant 
(p<0.0001).
Comparison of AgNOR count in different grades of OL 
and in OSCC: The three groups in 15 specimens of  OL 
was compared using the “ANOVA” test and showed sta-
tistically no significant results (p> 0.51). The two grades 
in 20 specimens of OSCC were compared using the “t” 
test and showed statistically no significant results (p> 
0.97)    (Table 2).
Diagnostic validity of AgNOR count in predicting can-
compared to cases of OL, with a statistically significant 
difference (p<0.0001) indicating a high proliferative ac-
tivity in former cases. The mean AgNOR count increa-
sed as the grade of dysplasia increased in cases of OL, 
where as in the cases of OSCC there was no stastically 
significant difference between well and moderately di-
fferentiated OSCC. The AgNOR count has been thought 
to be a proliferation marker; therefore one would find a 
difference in normal mucosa, OL and OSCC as reported 
in literature (12-16). 
The inter observer variation between the two observers in 
our study was highly statistically significant (p<0.0001) 
indicating that the AgNOR counting method employed 
in our study is reliable.
 Diagnostic validity of AgNOR count in predicting can-
cerous lesion was estimated by determining the cutoff 
value of AgNOR between precancer and cancer. In our 
study a cutoff value of 3.5 has been suggested, an Ag-
NOR value greater than 3.5 is suggestive of OSCC. In 
one study the cutoff value of 4.8 was proposed to diffe-
rentiate between benign and malignant lesions in brush 
biopsy cases of suspicious lesions of oral cavity (17). 
In another study a cutoff point of 2.37 was proposed to 
differentiate between nondysplastic and dysplastic OL 
(16). Another study proposed that a mean AgNOR count 
>2.8 concurred with poor prognosis in OSCC and that 
T3 and T4 tumors >2.8 mean AgNOR counts were ag-
gressive and may exhibit resistance to current treatment 
protocols (12).
The higher AgNOR counts found in many cancers may 
be due to dispersion of AgNORs in the nucleoplasm, so 
the AgNOR type may be a helpful in making such a dis-
tinction, whether this indicates increased risk of malig-
nant transformation awaits longitudinal study (11).  The 
AgNOR dots in benign lesions shows a large, central, re-
gularly contoured nucleolus containing single or multi-
ple AgNOR dots, where as the malignant neoplasms had 
multiple small nucleoli with prominent AgNORs distri-
buted throughout the nucleus (5) as seen in our study. 
As with most histochemical markers of malignant trans-
formation, AgNOR would evidence the metabolic alte-







Mean AgNOR and 
standard deviation 
in different grades
Mean AgNOR and 
standard deviation
Oral leukoplakia mild dysplasia 05 2.14 – 3.66 2.59 ±0.66
2.80±0.50Oral leukoplakia moderate dyspla-sia 09 2.45 – 3.63 2.92± 0.43
Oral leukoplakia severe dyspalsia 01 2.79 2.79
Oral squamous cell 
carcinoma well differentiated 12 3.48-8.55 5.73 ±1.62 5.71±1.08
Oral squamous cell 
carcinoma
moderately diffe-
rentiated 08 4.33-8.27 5.67 ±1.19
Table 2. Histological grades of oral leukoplakia and oral squamous cell carcinoma
cerous lesion in our study was done by establishing a 
cutoff value, where in a cutoff value of greater than 3.5 
AgNOR count can be considered to differentiate bet-
ween OL and OSCC (Table 3). 
Discussion
The present study comparatively assessed the difference 
in the cell proliferation rates in the various histological 
grades of OL and OSCC by the AgNOR technique. The 







≥3.5 19 O3 22





Positive predictive value =19/22= 86.36 %
Negative predictive value =12/13= 92.31 %
Efficiency =31/35= 88.57 %
Table 3. Cutoff value (95th percentile of Precancer)
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than characterize malignancy as such (5). AgNORs de-
tect cellular alterations before morphologic expression.
In one study the degree of keratinisation and nucleolar 
activity was assessed in smokers by obtaining cytologi-
cal smears from the lateral aspect of the tongue using a 
wooden spatula and endobrush and also evaluated the 
depth of the cytological smears obtained by the two me-
thods on the lateral aspect of the tongue. The samples 
were stained with papanicolaou and the silver stain. 
Smokers with clinically normal mucosa showed a grea-
ter percentage of keratinized cells and greater nucleolar 
activity, and the cytological smears obtained from the 
endobrush revealed deeper cells, suggesting that cigaret-
te smoking influences the cellular activity of the mucosa 
of the lateral tongue (18).
In another study the percentage of the number AgNORs 
present in the nucleus was analyzed, and was propo-
sed that the pAgNOR >1 or>2 reflects the size of the 
growth fraction as well as its proliferative activity. This 
is consistent with the observation that high proliferative 
activity coincides with poor prognosis. They proposed 
that the pAgNOR>1 were strong indicators with regard 
to disease recurrence and short survival in T1 and T2 
OSCC (14).
In our study two cases of well differentiated (8.55, 
8.55) and one case of moderately differentiated (8.27) 
OSCC showed high Mean AgNOR counts, which were 
well beyond the Mean AgNOR count of 5.73± 1.62 for 
well  differentiated and 5.67±1.19 for moderately diffe-
rentiated OSCC. The hematoxylin and eosin sections 
showed high mitotic figures even though they were well 
and moderately differentiated OSCC. Sano  et al. (19) 
proposed that the 5year survival rate of cases with high 
AgNOR counts (≥6.5) was significantly lower than that 
of counts (<6.5). Therefore they proposed that AgNOR 
counts might be a useful marker in assessing the progno-
sis of the malignant lesion. Based on this proposition the 
AgNOR counts in our study showing very high values 
may be marked as having poor prognosis. Therefore the 
AgNOR method can be used to provide information on 
the malignant potentiality in premalignant lesions and 
aggressiveness of the malignant lesions. 
To draw substantial conclusions as to whether AgNOR 
counts indicate increased risk of malignant transforma-
tion awaits longitudinal study with larger samples.
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